1. Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: A phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial;Absalon;The Lancet Infectious Diseases,2021
2. Anderson, A.S., Bhalla, A.S.B., DONALD, R.G.K., Gu, J., Jansen, K.U., Kainthan, R.K., Khandke, L., Kim, J.-H., Liberator, P., PRASAD, A.K., Ruppen, M.E., Scully, I.L., Singh, S., & Yang, C.X. (2016). Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof (World Intellectual Property Organization Patente WO2016178123A1). https://patents.google.com/patent/WO2016178123A1/en?oq=WO2016178123a.
3. Carbohydrate vaccines: Developing sweet solutions to sticky situations?;Astronomo;Nature Reviews Drug Discovery,2010
4. Novel strategies for development of next-generation glycoconjugate vaccines;Avci;Current Topics in Medicinal Chemistry,2013
5. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus;Baker;The New England Journal of Medicine,1988